PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 57.30
+0.10 (0.17%)
Oct 12, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 8.23 billion as of October 12, 2026. It is the 19,436th most valuable company in the world and the 843rd biggest in Taiwan. Its market cap has decreased by 20.42% in one year.
Market Cap
8.23B
Enterprise Value
3.20B
Revenue
1.03B
Global Rank
Country Rank
#843 Taiwan
PE Ratio
15.28
ChartMarket Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 8.23B, an increase of 53.06%. That is a compound annual growth rate of 2.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 8.23B | -18.61% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 10.32B |
| Locus Cell | 9.82B |
| TCM Biotech International | 9.80B |
| Tanvex BioPharma | 9.00B |
| Adimmune | 8.09B |
| AnnJi Pharmaceutical | 7.85B |
| Acepodia | 7.81B |
| Polaris Group | 7.76B |